356 related articles for article (PubMed ID: 34487324)
1. Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease.
Shi Q; Chen C; Xiao K; Zhou W; Gao LP; Chen DD; Wu YZ; Wang Y; Hu C; Gao C; Dong XP
Neurosci Bull; 2021 Nov; 37(11):1570-1582. PubMed ID: 34487324
[TBL] [Abstract][Full Text] [Related]
2. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay.
Sano K; Satoh K; Atarashi R; Takashima H; Iwasaki Y; Yoshida M; Sanjo N; Murai H; Mizusawa H; Schmitz M; Zerr I; Kim YS; Nishida N
PLoS One; 2013; 8(1):e54915. PubMed ID: 23372790
[TBL] [Abstract][Full Text] [Related]
3. Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.
Takada LT; Kim MO; Cleveland RW; Wong K; Forner SA; Gala II; Fong JC; Geschwind MD
Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):36-69. PubMed ID: 27943639
[TBL] [Abstract][Full Text] [Related]
4. Profiles of 14-3-3 and Total Tau in CSF Samples of Chinese Patients of Different Genetic Prion Diseases.
Chen C; Hu C; Shi Q; Zhou W; Xiao K; Wang Y; Liu L; Chen J; Xia Y; Dong XP
Front Neurosci; 2019; 13():934. PubMed ID: 31551692
[TBL] [Abstract][Full Text] [Related]
5. Prion Mutations in Republic of Republic of Korea, China, and Japan.
Kim DY; Shim KH; Bagyinszky E; An SSA
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614069
[TBL] [Abstract][Full Text] [Related]
6. Different reactive profiles of calmodulin in the CSF samples of Chinese patients of four types of genetic prion diseases.
Jia XX; Hu C; Chen C; Gao LP; Liang DL; Zhou W; Cao RD; Xiao K; Shi Q; Dong XP
Front Mol Neurosci; 2024; 17():1341886. PubMed ID: 38390431
[TBL] [Abstract][Full Text] [Related]
7. Rare genetic Creutzfeldt-Jakob disease with E196A mutation: a case report.
Dai Y; Lang Y; Ding M; Zhang B; Han X; Duan G; Cui L
Prion; 2019 Jan; 13(1):132-136. PubMed ID: 31238786
[TBL] [Abstract][Full Text] [Related]
8. The Features of Genetic Prion Diseases Based on Chinese Surveillance Program.
Shi Q; Zhou W; Chen C; Zhang BY; Xiao K; Zhang XC; Shen XJ; Li Q; Deng LQ; Dong JH; Lin WQ; Huang P; Jiang WJ; Lv J; Han J; Dong XP
PLoS One; 2015; 10(10):e0139552. PubMed ID: 26488179
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification.
Baiardi S; Rossi M; Mammana A; Appleby BS; Barria MA; Calì I; Gambetti P; Gelpi E; Giese A; Ghetti B; Herms J; Ladogana A; Mikol J; Pal S; Ritchie DL; Ruf V; Windl O; Capellari S; Parchi P
Acta Neuropathol; 2021 Oct; 142(4):707-728. PubMed ID: 34324063
[TBL] [Abstract][Full Text] [Related]
10. Genetic prion disease: the EUROCJD experience.
Kovács GG; Puopolo M; Ladogana A; Pocchiari M; Budka H; van Duijn C; Collins SJ; Boyd A; Giulivi A; Coulthart M; Delasnerie-Laupretre N; Brandel JP; Zerr I; Kretzschmar HA; de Pedro-Cuesta J; Calero-Lara M; Glatzel M; Aguzzi A; Bishop M; Knight R; Belay G; Will R; Mitrova E;
Hum Genet; 2005 Nov; 118(2):166-74. PubMed ID: 16187142
[TBL] [Abstract][Full Text] [Related]
11. Creutzfeldt-Jakob disease associated with a T188K homozygous mutation in the prion protein gene: a case report and review of the literature.
Shan Y; Zhang J; Cen Y; Xu X; Tan R; Zhao J; Yu S
Prion; 2022 Dec; 16(1):14-18. PubMed ID: 35130121
[TBL] [Abstract][Full Text] [Related]
12. Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases.
Higuma M; Sanjo N; Satoh K; Shiga Y; Sakai K; Nozaki I; Hamaguchi T; Nakamura Y; Kitamoto T; Shirabe S; Murayama S; Yamada M; Tateishi J; Mizusawa H
PLoS One; 2013; 8(3):e60003. PubMed ID: 23555862
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Clinical and Pathophysiological Features of Genetic Creutzfeldt-Jakob Disease Caused by a Val-to-Ile Mutation at Codon 180 in the Prion Protein Gene.
Matsubayashi T; Sanjo N
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499498
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Chinese patients with genetic CJD who have E196A or E196K mutation in
Shi Q; Xiao K; Chen C; Zhou W; Gao LP; Wu YZ; Wang Y; Hu C; Gao C; Dong XP
BMJ Open; 2021 Nov; 11(11):e054551. PubMed ID: 34782343
[TBL] [Abstract][Full Text] [Related]
15. A patient with spastic paralysis finally diagnosed as V180I genetic Creutzfeldt-Jakob disease 9 years after onset.
Nomura T; Iwata I; Naganuma R; Matsushima M; Satoh K; Kitamoto T; Yabe I
Prion; 2020 Dec; 14(1):226-231. PubMed ID: 32938301
[TBL] [Abstract][Full Text] [Related]
16. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010.
Gao C; Shi Q; Tian C; Chen C; Han J; Zhou W; Zhang BY; Jiang HY; Zhang J; Dong XP
PLoS One; 2011; 6(8):e24231. PubMed ID: 21904617
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients.
Zerr I; Villar-Piqué A; Schmitz VE; Poleggi A; Pocchiari M; Sánchez-Valle R; Calero M; Calero O; Baldeiras I; Santana I; Kovacs GG; Llorens F; Schmitz M
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31795176
[TBL] [Abstract][Full Text] [Related]
18. The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol.
Bregman N; Shiner T; Kavé G; Alcalay R; Gana-Weisz M; Goldstein O; Glinka T; Aizenstein O; Bashat DB; Alcalay Y; Mirelman A; Thaler A; Giladi N; Omer N
BMC Neurol; 2023 Apr; 23(1):151. PubMed ID: 37069531
[TBL] [Abstract][Full Text] [Related]
19. Clinical and familial characteristics of eight Chinese patients with T188K genetic Creutzfeldt-Jakob disease.
Chen C; Shi Q; Zhou W; Zhang XC; Dong JH; Hu XQ; Song XN; Liu AF; Tian C; Wang JC; Gao C; Zhang J; Han J; Dong XP
Infect Genet Evol; 2013 Mar; 14():120-4. PubMed ID: 23261545
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
Schmitz M; Villar-Piqué A; Hermann P; Escaramís G; Calero M; Chen C; Kruse N; Cramm M; Golanska E; Sikorska B; Liberski PP; Pocchiari M; Lange P; Stehmann C; Sarros S; Martí E; Baldeiras I; Santana I; Žáková D; Mitrová E; Dong XP; Collins S; Poleggi A; Ladogana A; Mollenhauer B; Kovacs GG; Geschwind MD; Sánchez-Valle R; Zerr I; Llorens F
Brain; 2022 Apr; 145(2):700-712. PubMed ID: 35288744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
